1. Home

Research Group receive Innovate UK ICURe SETsquared Award

We are delighted to be currently taking part in the UKRI Innovate UK ICURe SETsquared Cohort 32 (32-08 / 520268133: £30,000). This programme is allowing us to market validate our peptide hydrogel technology in a variety of applications both within drug delivery and the wider commercial landscape.

Our Research Associate Simon Porter is currently undertaking these activities remotely via conference attendance and engagement.

Further information on the programme can be found at the link below:

ICURe SETsquared Cohort 32

Related News


Advanced Science News Coverage and Advanced Healthcare Materials paper

Our recent research into using peptide hydrogels as long-acting injectable implants for HIV/AIDS drug delivery has be covered by Advanced Science News. This provides an oversight of our most recent publication within Advanced Healthcare Materials. A link to both can be found below: Advanced Science News Advanced Healthcare Materials    

Our EPSRC research selected as case study

Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]

Publication of group’s educational paper on industrial pharmaceutical formulation

Our group’s educational paper “Development of a teaching model to advance skills in industrial pharmaceutical formulation and regulatory aspects,” has now been published in Currents in Pharmacy Teaching and Learning. A free link to the article is provided below, valid before January 26th 2019. Thanks to all those who contributed to the article, especially the BSc […]

PhD positions available within our group: 7th January 2019 deadline

A number of PhD positions are available within the group. Funding will be allocated to successful applicants rather, than project. Successful applicant will receive tuition fees(UK/EU) paid and a stipend (for UK residents only). Closing date for all applications is 7th January 2019 with interviews being scheduled for February 2019.   Dr Garry Laverty (First […]

Latest paper from group: Investigating the In Vivo Antimicrobial Activity of a Self-Assembling Peptide Hydrogel Using a Galleria mellonella Infection Model

Our latest research paper is now freely available via the journal ACS Omega, whereby we use an innovative waxworm (Galleria mellonella) model as an alternative to mammalian/vertebrate testing. The following assay can be very simply performed without any specific ethical approval or animal licenses. We successfully employed the methods outlined to study the antimicrobial efficacy […]

OUR RESEARCH IS FUNDED BY

Contact Us
  • +44 (0) 28 9097 2273
  • garry.laverty@qub.ac.uk
  • School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, Co. Antrim, N.Ireland. BT97BL
  • Get Directions
Quick Links
Laverty Lab